Literature DB >> 33199839

Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer.

Yeon Bi Han1,2, Hyojin Kim1,2, Mari Mino-Kenudson3, Sukki Cho4, Hyun Jung Kwon1,2, Ki Rim Lee1,2, Soohyeon Kwon1,2, Jeonghyo Lee1,2, Kwhanmien Kim4, Sanghoon Jheon4, Choon-Taek Lee5, Jong-Seok Lee5, Woong Kook6, Jin-Haeng Chung7,8.   

Abstract

Tumor spread through air spaces (STAS) is an invasive pattern of lung cancer that was recently described. In this study, we investigated the association between the extent of STAS and clinicopathological characteristics and patient outcomes in resected non-small cell lung cancers (NSCLCs). STAS has been prospectively described from 2008 and graded its extent with a two-tiered system (STAS I: <2500 μm [one field of ×10 objective lens] from the edge of tumor and STAS II: ≥2500 μm from the edge of tumor) from 2011 in Seoul National University Bundang Hospital. We retrospectively analyzed the correlations between the extent of STAS and clinicopathologic characteristics and prognostic significance in 1869 resected NSCLCs. STAS was observed in 765 cases (40.9%) with 456 STAS I (24.4%) and 309 STAS II (16.5%). STAS was more frequently found in patients with adenocarcinoma (ADC) (than squamous cell carcinoma), pleural invasion, lymphovascular invasion, and/or higher pathologic stage. In ADC, there were significant differences in recurrence free survival (RFS), overall survival (OS), and lung cancer specific survival (LCSS) according to the extent of STAS. In stage IA non-mucinous ADC, multivariate analysis revealed that STAS II was significantly associated with shorter RFS and LCSS (p < 0.001 and p = 0.006, respectively). In addition, STAS II was an independent poor prognostic factor for recurrence in both limited and radical resection groups (p = 0.001 and p = 0.023, respectively). In conclusion, presence of STAS II was an independent poor prognostic factor in stage IA non-mucinous ADC regardless of the extent of resection.

Entities:  

Year:  2020        PMID: 33199839     DOI: 10.1038/s41379-020-00709-2

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer.

Authors:  Shuai Wang; Huankai Shou; Haoyu Wen; Xingxing Wang; Haixing Wang; Chunlai Lu; Jie Gu; Fengkai Xu; Qiaoliang Zhu; Lin Wang; Di Ge
Journal:  BMC Pulm Med       Date:  2022-05-26       Impact factor: 3.320

Review 2.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis.

Authors:  Jung-Soo Pyo; Nae Yu Kim
Journal:  Diagnostics (Basel)       Date:  2022-04-28

4.  Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma.

Authors:  Sami Dagher; Abdulrazzaq Sulaiman; Sophie Bayle-Bleuez; Claire Tissot; Valérie Grangeon-Vincent; David Laville; Pierre Fournel; Olivier Tiffet; Fabien Forest
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

Review 5.  [Research Progress on Spread Through Air Spaces of Lung Cancer].

Authors:  Lei Fan; Ping He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-12-23

6.  The prognostic significance of tumor spread through air space in stage I lung adenocarcinoma.

Authors:  Liling Huang; Le Tang; Liyuan Dai; Yuankai Shi
Journal:  Thorac Cancer       Date:  2022-02-17       Impact factor: 3.500

Review 7.  [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].

Authors:  Chen Shen; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-08-20

8.  Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis.

Authors:  Shaonan Xie; Qingyi Liu; Yaqing Han; Shize Wang; Huiyan Deng; Guangjie Liu
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

9.  A systematic review and meta-analysis of the influence of STAS on the long-term prognosis of stage I lung adenocarcinoma.

Authors:  Yanhui Yang; Xiaoyang Xie; Yi Wang; Xiaoliang Li; Lei Luo; Yi Yao; Ji Li
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

10.  Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma.

Authors:  Wenyu Zhai; Dachuan Liang; Fangfang Duan; Wingshing Wong; Qihang Yan; Li Gong; Renchun Lai; Shuqin Dai; Hao Long; Junye Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.